SANA
Price:
$3.855
Market Cap:
$857.61M
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; SG221 and SG239 for the treatment of multiple myeloma; and SG328 for ornithine transcarbamylase deficiency. It also develops SG418 for sickle cell disease and beta-thalassemia;...[Read more]
Industry
Biotechnology
IPO Date
2021-02-04
Stock Exchange
NASDAQ
Ticker
SANA
According to Sana Biotechnology, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.20. This represents a change of 10.73% compared to the average of 4.69 of the last 4 quarters.
The mean historical Current Ratio of Sana Biotechnology, Inc. over the last ten years is 8.45. The current 5.20 Current Ratio has changed 6.05% with respect to the historical average. Over the past ten years (40 quarters), SANA's Current Ratio was at its highest in in the March 2021 quarter at 27.52. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
8.45
Median
6.45
Minimum
3.31
Maximum
18.26
Discovering the peaks and valleys of Sana Biotechnology, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 68.02%
Maximum Annual Current Ratio = 18.26
Minimum Annual Increase = -60.16%
Minimum Annual Current Ratio = 3.31
Year | Current Ratio | Change |
---|---|---|
2023 | 3.31 | -16.93% |
2022 | 3.99 | -29.13% |
2021 | 5.62 | -53.99% |
2020 | 12.22 | 68.02% |
2019 | 7.28 | -60.16% |
The current Current Ratio of Sana Biotechnology, Inc. (SANA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.31
5-year avg
6.48
10-year avg
8.45
Sana Biotechnology, Inc.’s Current Ratio is less than Olema Pharmaceuticals, Inc. (9.13), less than Cullinan Oncology, Inc. (28.87), less than aTyr Pharma, Inc. (6.07), less than Zentalis Pharmaceuticals, Inc. (6.59), less than X4 Pharmaceuticals, Inc. (6.07), less than Galera Therapeutics, Inc. (5.63), less than Terns Pharmaceuticals, Inc. (21.02), greater than Day One Biopharmaceuticals, Inc. (4.09), greater than HOOKIPA Pharma Inc. (3.86), less than Revolution Medicines, Inc. (15.42), greater than Blueprint Medicines Corporation (3.71), less than Kymera Therapeutics, Inc. (8.45), less than Monte Rosa Therapeutics, Inc. (6.56), less than Nkarta, Inc. (15.91), less than Lyell Immunopharma, Inc. (16.19), less than Generation Bio Co. (7.42), less than Mirati Therapeutics, Inc. (7.54), greater than Amylyx Pharmaceuticals, Inc. (4.66), greater than Apellis Pharmaceuticals, Inc. (5.08),
Company | Current Ratio | Market cap |
---|---|---|
9.13 | $664.29M | |
28.87 | $930.52M | |
6.07 | $131.12M | |
6.59 | $217.95M | |
6.07 | $84.49M | |
5.63 | $3.97M | |
21.02 | $633.69M | |
4.09 | $1.21B | |
3.86 | $46.17M | |
15.42 | $8.42B | |
3.71 | $5.61B | |
8.45 | $2.85B | |
6.56 | $300.73M | |
15.91 | $268.12M | |
16.19 | $293.12M | |
7.42 | $158.18M | |
7.54 | $4.12B | |
4.66 | $242.37M | |
5.08 | $3.25B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sana Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sana Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Sana Biotechnology, Inc.'s Current Ratio?
How is the Current Ratio calculated for Sana Biotechnology, Inc. (SANA)?
What is the highest Current Ratio for Sana Biotechnology, Inc. (SANA)?
What is the 3-year average Current Ratio for Sana Biotechnology, Inc. (SANA)?
What is the 5-year average Current Ratio for Sana Biotechnology, Inc. (SANA)?
How does the current Current Ratio for Sana Biotechnology, Inc. (SANA) compare to its historical average?